Balkrishna Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

Results View source PDF Explain this filing

BALKRISIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹2403.60

prior close

₹2419.50

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.1%-1.7% vs market

Tyres & Rubber Products peers, median of 15sector-1.1%-0.5% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Midcap 150 and 0.5 pts less than its Tyres & Rubber Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.5

10m

-1.4

15m

-1.4

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.1-1.7-1.1-0.5

Next day

-4.1+0.1-4.2-0.6-3.5

-4.7-1.0-3.7-2.3-2.4

+6.1+1.9+4.2+1.0+5.2

+11.7+2.5+9.2+1.9+9.8

+11.4+2.2+9.2+1.0+10.4

+11.3+3.8+7.5+1.2+10.0

15d

+5.3+1.6+3.6+0.2+5.0

-4.0+0.1-4.0-6.1+2.2

-13.7-9.5-4.2-18.4+4.8

-8.4+3.5-11.9-5.4-3.0

UpDownMarket · Nifty Midcap 150Sector · Tyres & Rubber Products peers, median of 15Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Balkrishna Industries Limited has filed its quarterly financial results with the stock exchange for the three months ended December 31, 2025. The headline only confirms the submission of results and does not include the actual revenue, profit, or margin figures. Investors will need to review the detailed results PDF to assess the company's Q3 performance. No comparison with previous quarters or year-ago period is provided in this filing text.

Likely market impact

Neutral in isolation — the filing is a routine regulatory submission. The actual direction of the stock will depend on whether the detailed numbers beat, match, or miss street expectations.